Suppr超能文献

肝硬化基础上结核性腹膜炎患者腺苷脱氨酶活性。

Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan, China.

出版信息

World J Gastroenterol. 2012 Oct 7;18(37):5260-5. doi: 10.3748/wjg.v18.i37.5260.

Abstract

AIM

To investigate the value of adenosine deaminase (ADA) for early detection of tuberculous peritonitis (TBP) among cirrhotic patients.

METHODS

We retrospectively analyzed 22 patients with TBP from July 1990 to June 2010. Twenty-five cirrhotic patients with uninfected ascites were prospectively enrolled as the cirrhosis control group from July 2010 to June 2011. An additional group of 217 patients whose ascites ADA levels were checked in various clinical conditions were reviewed from July 2008 to June 2010 as the validation group.

RESULTS

The mean ascites ADA value of cirrhotic patients with TBP (cirrhotic TBP group, n = 8) was not significantly different from that of non-cirrhotic patients (non-cirrhotic TBP group, n = 14; 58.1 ± 18.8 U/L vs. 70.6 ± 29.8 U/L, P = 0.29), but the mean ascites ADA value of the cirrhotic TBP group was significantly higher than that of the cirrhosis control group (58.1 ± 18.8 U/L vs. 7.0 ± 3.7 U/L, P < 0.001). ADA values were correlated with total protein values (r = 0.909, P < 0.001). Using 27 U/L as the cut-off value of ADA, the sensitivity and specificity were 100% and 93.3%, respectively, for detecting TBP in the validation group.

CONCLUSION

Even with lower ADA activity in ascites among cirrhotic patients, ADA values were significantly elevated during TBP, indicating that ADA can still be a valuable diagnostic tool.

摘要

目的

探讨腺苷脱氨酶(ADA)在肝硬化患者中对结核性腹膜炎(TBP)早期检测的价值。

方法

回顾性分析 1990 年 7 月至 2010 年 6 月期间 22 例 TBP 患者。前瞻性纳入 2010 年 7 月至 2011 年 6 月期间 25 例无感染性腹水的肝硬化患者作为肝硬化对照组。回顾性纳入 2008 年 7 月至 2010 年 6 月期间因各种临床情况检查腹水 ADA 水平的 217 例患者作为验证组。

结果

肝硬化合并 TBP 患者(肝硬化 TBP 组,n = 8)腹水 ADA 值与非肝硬化 TBP 患者(非肝硬化 TBP 组,n = 14)无显著差异(58.1 ± 18.8 U/L 比 70.6 ± 29.8 U/L,P = 0.29),但肝硬化 TBP 组腹水 ADA 值明显高于肝硬化对照组(58.1 ± 18.8 U/L 比 7.0 ± 3.7 U/L,P < 0.001)。ADA 值与总蛋白值呈正相关(r = 0.909,P < 0.001)。在验证组中,以 27 U/L 作为 ADA 的临界值,ADA 对 TBP 的敏感性和特异性分别为 100%和 93.3%。

结论

即使肝硬化患者腹水 ADA 活性较低,TBP 时 ADA 值仍显著升高,表明 ADA 仍然是一种有价值的诊断工具。

相似文献

引用本文的文献

4
Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.肝硬化合并结核病——诊断与管理难题
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):278-286. doi: 10.1016/j.jceh.2021.09.003. Epub 2021 Sep 10.
5
Diagnosis of Peritoneal Tuberculosis from Primary Peritoneal Cancer.原发性腹膜癌与结核性腹膜炎的鉴别诊断。
Int J Environ Res Public Health. 2021 Oct 3;18(19):10407. doi: 10.3390/ijerph181910407.
8
Diagnosing peritoneal tuberculosis.诊断腹膜结核。
BMJ Case Rep. 2020 Feb 6;13(2):e233131. doi: 10.1136/bcr-2019-233131.

本文引用的文献

2
Tuberculous peritonitis: analysis of 211 cases in Taiwan.结核性腹膜炎:台湾 211 例病例分析。
Dig Liver Dis. 2012 Feb;44(2):111-7. doi: 10.1016/j.dld.2011.08.020. Epub 2011 Sep 25.
9
Clinical practice. Pleural effusion.临床实践。胸腔积液。
N Engl J Med. 2002 Jun 20;346(25):1971-7. doi: 10.1056/NEJMcp010731.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验